107 related articles for article (PubMed ID: 28482574)
21. Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.
Zhao R; Li T; Zheng G; Jiang K; Fan L; Shao J
Biomaterials; 2017 Oct; 143():1-16. PubMed ID: 28755539
[TBL] [Abstract][Full Text] [Related]
22. Ligand-conjugated mesoporous silica nanorattles based on enzyme targeted prodrug delivery system for effective lung cancer therapy.
Sundarraj S; Thangam R; Sujitha MV; Vimala K; Kannan S
Toxicol Appl Pharmacol; 2014 Mar; 275(3):232-43. PubMed ID: 24467950
[TBL] [Abstract][Full Text] [Related]
23. Targeted delivery of a novel anticancer compound anisomelic acid using chitosan-coated porous silica nanorods for enhancing the apoptotic effect.
Senthilkumar R; Karaman DŞ; Paul P; Björk EM; Odén M; Eriksson JE; Rosenholm JM
Biomater Sci; 2015 Jan; 3(1):103-11. PubMed ID: 26214194
[TBL] [Abstract][Full Text] [Related]
24. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
25. Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy.
Zheng G; Zhao R; Xu A; Shen Z; Chen X; Shao J
Eur J Pharm Sci; 2018 Jan; 111():492-502. PubMed ID: 29107835
[TBL] [Abstract][Full Text] [Related]
26. Superiority of amino-modified chiral mesoporous silica nanoparticles in delivering indometacin.
Li J; Guo Y; Li H; Shang L; Li S
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1085-1094. PubMed ID: 28776393
[TBL] [Abstract][Full Text] [Related]
27. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
28. Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells.
Zhou S; Wu D; Yin X; Jin X; Zhang X; Zheng S; Wang C; Liu Y
J Exp Clin Cancer Res; 2017 Feb; 36(1):24. PubMed ID: 28166836
[TBL] [Abstract][Full Text] [Related]
29. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy.
Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L
Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341
[TBL] [Abstract][Full Text] [Related]
30. A cancer-targeted nanosystem for delivery of gold(III) complexes: enhanced selectivity and apoptosis-inducing efficacy of a gold(III) porphyrin complex.
He L; Chen T; You Y; Hu H; Zheng W; Kwong WL; Zou T; Che CM
Angew Chem Int Ed Engl; 2014 Nov; 53(46):12532-6. PubMed ID: 25220408
[TBL] [Abstract][Full Text] [Related]
31. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
[TBL] [Abstract][Full Text] [Related]
32. Mesoporous silica nanoparticles (MSNs)-based organic/inorganic hybrid nanocarriers loading 5-Fluorouracil for the treatment of colon cancer with improved anticancer efficacy.
Pan G; Jia TT; Huang QX; Qiu YY; Xu J; Yin PH; Liu T
Colloids Surf B Biointerfaces; 2017 Nov; 159():375-385. PubMed ID: 28818782
[TBL] [Abstract][Full Text] [Related]
33. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
34. Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin.
Lin CH; Cheng SH; Liao WN; Wei PR; Sung PJ; Weng CF; Lee CH
Int J Pharm; 2012 Jun; 429(1-2):138-47. PubMed ID: 22465413
[TBL] [Abstract][Full Text] [Related]
35. Rational design of curcumin loaded multifunctional mesoporous silica nanoparticles to enhance the cytotoxicity for targeted and controlled drug release.
Chen C; Sun W; Wang X; Wang Y; Wang P
Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():88-96. PubMed ID: 29407161
[TBL] [Abstract][Full Text] [Related]
36. Ammonium salt modified mesoporous silica nanoparticles for dual intracellular-responsive gene delivery.
Li Y; Hei M; Xu Y; Qian X; Zhu W
Int J Pharm; 2016 Sep; 511(2):689-702. PubMed ID: 27426108
[TBL] [Abstract][Full Text] [Related]
37. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
38. Management of retinoblastoma: opportunities and challenges.
Bhavsar D; Subramanian K; Sethuraman S; Krishnan UM
Drug Deliv; 2016 Sep; 23(7):2488-2496. PubMed ID: 25758593
[TBL] [Abstract][Full Text] [Related]
39. Mesoporous silica nanoparticles functionalized with hyaluronic acid. Effect of the biopolymer chain length on cell internalization.
Nairi V; Magnolia S; Piludu M; Nieddu M; Caria CA; Sogos V; Vallet-Regì M; Monduzzi M; Salis A
Colloids Surf B Biointerfaces; 2018 Aug; 168():50-59. PubMed ID: 29456044
[TBL] [Abstract][Full Text] [Related]
40. In vivo intraocular distribution and safety of periocular nanoparticle carboplatin for treatment of advanced retinoblastoma in humans.
Kalita D; Shome D; Jain VG; Chadha K; Bellare JR
Am J Ophthalmol; 2014 May; 157(5):1109-15. PubMed ID: 24503408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
